Management of malignant pleural effusions.

Ruckdeschel, J C

Ruckdeschel, J C.

Afiliación

Ruckdeschel JC; H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa 33612-9497, USA.

Semin Oncol ; 22(2 Suppl 3): 58-63, 1995 Apr.

Article en En | MEDLINE | ID: mdl-7740322

RESUMEN

Malignant pleural effusions are a common complication of advanced cancer, particularly breast and lung cancers. Clinical algorithms for the diagnosis and management of malignant pleural effusions form a framework for the cost-effective provision of meaningful palliation. When the entire episode of care is considered, the optimal therapy for malignant pleural effusions appears to be tube thoracostomy followed by intrapleural bleomycin. Alternative strategies for the delivery of intrapleural therapy (eg, soft catheters) and new intrapleural agents currently are being compared with standard therapy.

Asunto(s)

Derrame Pleural Maligno/diagnóstico; Derrame Pleural Maligno/terapia; Algoritmos; Costo de Enfermedad; Análisis Costo-Beneficio; Humanos; Selección de Paciente; Derrame Pleural Maligno/economía; Pleurodesia/economía

Buscar en Google

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Derrame Pleural Maligno Límite: Humans Idioma: En Revista: Semin Oncol Año: 1995 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Buscar en Google

Añadir a Mi BVS

Imprimir

XML

PubMed Links